Media Coverage

March 5, 2018
Skin Cancer Doesn’t Discriminate: Finding the Best Treatment Options for a Nonmelanoma Skin Cancer Diagnosis
Dermascope | March 208

February 28, 2018
Innovative Breast Cancer Treatment Saves Patients Money and Offers Significant Health Benefits
Clinician Today

January 19, 2018
An Innovative Treatment Option for Early-Stage Breast Cancer
The Doctor Weighs In

January 16, 2018
Innovations in Geriatrics: Nonmelanoma Skin Cancer — Prevention, Diagnosis, and Treatment
Today's Geriatric Medicine

January 02, 2018
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
Imaging Technology News

December 19, 2017
Intraoperative Radiotherapy Provides Lifetime Cost Savings, Health Benefits for Early-Stage Breast Cancer Treatment
Imaging Technology News

December 12, 2017
IORT Study Highlights Economic, Health Benefits
24x7 Magazine

December 6, 2017
How to Avoid, Detect, and Treat Skin Cancer Year-Round

September 29, 2017
New Skin Cancer Treatment Now Available in Phoenix
Arizona Health and Living

September 26, 2017
Dr. Blair: Painless, non-invasive treatment for skin cancer now available
Paradise Valley Independent

September 26, 2017
Painless, Non-Invasive Treatment for Non-melanoma Skin Cancer Offers Patients a Convenient Alternative
Practical Dermatology

September 21, 2017
What Are the Side Effects of Surgery and Radiation Therapy for Breast Cancer?
U.S. News and World Report

September 7, 2017
China approves iCAD Xoft Axxent balloon applicators for early-stage breast cancer treatment

August 31, 2017
iCAD Gains CFDA Approval to Market Brachytherapy Device in China
ChinaBio Today

August 30, 2017
China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
Imaging Technology News

August 30, 2017
ICAD's Xoft Axxent balloon applicators receive China FDA approval for early stage breast cancer
Applied Radiation Oncology

August 9, 2017
Electronic brachytherapy lowers dose to OARs

August 3, 2017
Clinical Data Supports Use of Xoft System for Endometrial Cancer
Imaging Technology News

July 20, 2017
Electronic Brachytherapy Comparable to Mohs Surgery in Early-Stage Non-Melanoma Skin Cancer Treatment
Imaging Technology News

June 29, 2017
How One-Day Breast Cancer Treatment Offers Hope
USA Today

June 29, 2017
Nonmelanoma Skin Cancer: Warning Signs and Treatments

May 16, 2017
Paula’s Breast Cancer Treatment – New Clinical Trial
KDVR-TV "Colorado's Best" (FOX Denver, CO)

May 8, 2017
Xoft System Offers Benefits in Treatment of Uterine and Cervical Cancer, Studies Report
Cervical Cancer News

May 5, 2017
Researchers present first-ever European analysis of electronic brachytherapy using Xoft System for endometrial and cervical cancer treatment at ESTRO Meeting
Radiology Business Journal

May 2, 2017
Australia’s Monash Cancer Centre is First to Treat Breast Cancer Patient with iCAD’s Xoft System

May 1, 2017
Australia's Monash Cancer Centre Treats First Early-Stage Breast Cancer Patient With Xoft System
Imaging Technology News

May 1, 2017
Electronic Brachytherapy for Nonmelanoma Skin Cancer
Oncology Times

April 27, 2017
ICAD Displaying its Radiation System for Residual Breast Cancer at Conference

April 20, 2017
New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
Imaging Technology News

March 15, 2017
Xoft System Treats 3,000 Early-Stage Breast Cancer Patients With Intraoperative Radiation Therapy
Imaging Technology News

March 10, 2017
Revolutionary Design of eBx Technology Offers Clinicians More Options
Medical Device + Diagnostic Industry


» Archive »

Quick Links


Press Releases

Media Coverage

Tradeshow Calendar

Media Inquiries

Erin Bocherer
855.300.8209 ext 120

©2018 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.  Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.